Trending news

BioCentury extensively quotes Konstantin Linnik on the decision to hold Prometheus’ Diagnostic Method Claim Unpatentable

Print PDF

Konstantin Linnik, a member of the firm’s Intellectual Property practice group, was quoted extensively in the BioCentury article “Still Murky, Naturally” in the Politics, Policy & Law section on March 26th. The article discusses the U.S. Supreme Court’s ruling in Mayo Collaborative Services et. al. vs. Prometheus Laboratories Inc. and the uncertainty about what molecular diagnostic claims are patentable under Section 101 of the Patent Act. Konstantin responded to questions on how broadly the ruling may be applied to existing patents. “The court says you have to add steps that bring the inventive aspect of the invention rather than conventional known steps,” Konstantin said. “The question is what are non-conventional steps?”

More News >
Back to Page